NR4A1 and cancer: According to another recent study on patients with all-stage breast cancer conducted using only California Cancer Registry data, the stage at diagnosis accounted for 24% of the differences in cancer-specific survival, whereas hormone receptor (HoR) status accounted for 9% and neighborhood SES accounted for 6% [9].